ALS MMP-INHIBITOREN VERWENDETE HYDANTOINDERIVATE

ALS MMP-INHIBITOREN VERWENDETE HYDANTOINDERIVATE

The invention provides compounds of formula (I): wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHAPMAN, DAVID, GABOS, BALINT, MUNCK AF ROSENSCHOLD, MAGNUS
Format: Patent
Sprache:ger
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHAPMAN, DAVID
GABOS, BALINT
MUNCK AF ROSENSCHOLD, MAGNUS
description The invention provides compounds of formula (I): wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE517101TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE517101TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE517101TT13</originalsourceid><addsrcrecordid>eNrjZDBw9AlW8PUN0PX08_B08gzxD3L1UwhzDQp39XNxDXFV8Ih0cfQL8fcE8oI8wxxDXHkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSTxQpamhuaGBYUiIoTExagBehSck</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ALS MMP-INHIBITOREN VERWENDETE HYDANTOINDERIVATE</title><source>esp@cenet</source><creator>CHAPMAN, DAVID ; GABOS, BALINT ; MUNCK AF ROSENSCHOLD, MAGNUS</creator><creatorcontrib>CHAPMAN, DAVID ; GABOS, BALINT ; MUNCK AF ROSENSCHOLD, MAGNUS</creatorcontrib><description>The invention provides compounds of formula (I): wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.</description><language>ger</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110815&amp;DB=EPODOC&amp;CC=AT&amp;NR=E517101T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110815&amp;DB=EPODOC&amp;CC=AT&amp;NR=E517101T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHAPMAN, DAVID</creatorcontrib><creatorcontrib>GABOS, BALINT</creatorcontrib><creatorcontrib>MUNCK AF ROSENSCHOLD, MAGNUS</creatorcontrib><title>ALS MMP-INHIBITOREN VERWENDETE HYDANTOINDERIVATE</title><description>The invention provides compounds of formula (I): wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw9AlW8PUN0PX08_B08gzxD3L1UwhzDQp39XNxDXFV8Ih0cfQL8fcE8oI8wxxDXHkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSTxQpamhuaGBYUiIoTExagBehSck</recordid><startdate>20110815</startdate><enddate>20110815</enddate><creator>CHAPMAN, DAVID</creator><creator>GABOS, BALINT</creator><creator>MUNCK AF ROSENSCHOLD, MAGNUS</creator><scope>EVB</scope></search><sort><creationdate>20110815</creationdate><title>ALS MMP-INHIBITOREN VERWENDETE HYDANTOINDERIVATE</title><author>CHAPMAN, DAVID ; GABOS, BALINT ; MUNCK AF ROSENSCHOLD, MAGNUS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE517101TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>CHAPMAN, DAVID</creatorcontrib><creatorcontrib>GABOS, BALINT</creatorcontrib><creatorcontrib>MUNCK AF ROSENSCHOLD, MAGNUS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHAPMAN, DAVID</au><au>GABOS, BALINT</au><au>MUNCK AF ROSENSCHOLD, MAGNUS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ALS MMP-INHIBITOREN VERWENDETE HYDANTOINDERIVATE</title><date>2011-08-15</date><risdate>2011</risdate><abstract>The invention provides compounds of formula (I): wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_ATE517101TT1
source esp@cenet
title ALS MMP-INHIBITOREN VERWENDETE HYDANTOINDERIVATE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T22%3A12%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHAPMAN,%20DAVID&rft.date=2011-08-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE517101TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true